Batch Record

Batch Record constitutes the comprehensive documentation capturing all manufacturing activities, observations, and data associated with producing a specific pharmaceutical batch from raw material receipt through final product release. This critical quality system element provides complete traceability, demonstrating that manufacturing occurred according to established procedures and met all predetermined specifications. Batch records encompass material reconciliation, equipment identification, process parameters, in process controls, environmental monitoring data, deviations, and personnel signatures, creating an auditable history of each production lot.

In regulated biopharmaceutical manufacturing, batch records serve as primary evidence of GMP compliance, subject to regulatory inspection and essential for product disposition decisions. The pharmaceutical industry has evolved from traditional paper based batch records toward electronic batch record (EBR) systems offering enhanced data integrity, real time review capabilities, reduced transcription errors, and streamlined deviation management. Implementing electronic systems requires validation demonstrating that software meets regulatory requirements including 21 CFR Part 11 compliance for electronic records and signatures. Batch record review represents a critical quality assurance function, with trained personnel verifying completeness, accuracy, and compliance before authorising product release. For biologics, batch records document complex multi step processes including cell culture, purification, formulation, and fill finish operations, often spanning weeks of production. Companies optimise batch record design balancing comprehensive documentation with operational efficiency, incorporating risk based approaches that focus critical documentation on parameters affecting product quality while minimising non value added record keeping activities that can introduce errors and delays.